ABO Stock Overview
Operates as an independent electricity producer from renewable energies in Europe. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 1/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
clearvise AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €1.80 |
52 Week High | €2.13 |
52 Week Low | €1.80 |
Beta | 0.22 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | -22.63% |
5 Year Change | -1.91% |
Change since IPO | 11.49% |
Recent News & Updates
Recent updates
Shareholder Returns
ABO | DE Renewable Energy | DE Market | |
---|---|---|---|
7D | 0% | -2.2% | 0.2% |
1Y | n/a | -32.9% | 8.5% |
Return vs Industry: Insufficient data to determine how ABO performed against the German Renewable Energy industry.
Return vs Market: Insufficient data to determine how ABO performed against the German Market.
Price Volatility
ABO volatility | |
---|---|
ABO Average Weekly Movement | n/a |
Renewable Energy Industry Average Movement | 3.3% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: ABO's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine ABO's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 14 | Petra Leue-Bahns | www.clearvise.de |
clearvise AG operates as an independent electricity producer from renewable energies in Europe. Its operational portfolio consists of wind and solar parks, and a biogas plant in four countries with an installed capacity of approximately 303 MW. The company was formerly known as ABO Invest AG and changed its name to clearvise AG in 2020.
clearvise AG Fundamentals Summary
ABO fundamental statistics | |
---|---|
Market cap | €128.86m |
Earnings (TTM) | €6.77m |
Revenue (TTM) | €39.68m |
19.0x
P/E Ratio3.2x
P/S RatioIs ABO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ABO income statement (TTM) | |
---|---|
Revenue | €39.68m |
Cost of Revenue | €127.50k |
Gross Profit | €39.55m |
Other Expenses | €32.78m |
Earnings | €6.77m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.09 |
Gross Margin | 99.68% |
Net Profit Margin | 17.06% |
Debt/Equity Ratio | 0% |
How did ABO perform over the long term?
See historical performance and comparison